Epstein Secrets

ed Veteran's Suicide. The Washington Post (7/28, Rein, 14.2M) reports that a veteran, "suffering in pain and out of medication, turned last year to the Veterans Affairs' flagship hospital in D.C. for help. Instead of receiving aid," a new report by the VA inspector general released Tuesday said, "a cascade of failur

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

4- d0e8-11ea-af07-1d058cal37ae_story.html> (7/28, Rein, 14.2M) reports that a veteran, "suffering in pain and out of medication, turned last year to the Veterans Affairs' flagship hospital in D.C. for help. Instead of receiving aid," a new report by the VA inspector general released Tuesday said, "a cascade of failure

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

ed Veteran's Suicide. The Washington Post (7/28, Rein, 14.2M) reports that a veteran, "suffering in pain and out of medication, turned last year to the Veterans Affairs' flagship hospital in D.C. for help. Instead of receiving aid," a new report by the VA inspector general released Tuesday said, "a cascade of failur

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

ed Veteran's Suicide. The Washington Post (7/28, Rein, 14.2M) reports that a veteran, "suffering in pain and out of medication, turned last year to the Veterans Affairs' flagship hospital in D.C. for help. Instead of receiving aid," a new report by the VA inspector general released Tuesday said, "a cascade of failur

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U